MOLECULAR TEMPLATES, INC.

Analyst Reco. Molecular Templates, Inc.

Equities

MTEM

US6085502085

Delayed Nasdaq Other stock markets 03:59:51 2024-05-07 pm EDT			5-day change	1st Jan Change
1.64 ^USD	0.00%		-3.01%	-56.84%

Apr. 12	Molecular Templates, Inc. Announces Cessation of Maurizio Voi as Chief Medical Officer, Effective April 30, 2024	CI
Apr. 09	Molecular Templates, Inc. Presents Interim Data from Mt-6402 Phase I Study in Patients with Pd-L1+ Solid Tumors At the 2024 American Association for Cancer Research Annual Meeting	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Barclays Adjusts Price Target on Molecular Templates to $1 From $4.50, Maintains Overweight Rating	22-11-11	MT
Stifel Nicolaus Adjusts Molecular Templates Price Target to $5 From $9, Maintains Buy Rating	22-08-12	MT
BofA Securities Downgrades Molecular Templates to Underperform From Buy, Sets Price Target at $1.50	22-05-27	MT
Stifel Adjusts Molecular Templates' Price Target to $9 From $11, Reiterates Buy Rating	22-05-16	MT
Barclays Adjusts Molecular Templates' Price Target to $4.50 from $8, Keeps Overweight Rating	22-03-30	MT
Oppenheimer Lowers Price Target for Molecular Templates to $9 From $13, Maintains Outperform Rating	21-12-01	MT
MOLECULAR TEMPLATES : UBS Adjusts PT on Molecular Templates to $8 From $13 on MT-3724 Discontinuation, TAK-169 Rights Reversion, MT-6402 Program Start; Neutral Rating Kept	21-07-30	MT
MOLECULAR TEMPLATES : BofA Securities Starts Molecular Templates at Buy with $12 Price Target	21-04-21	MT
MOLECULAR TEMPLATES : Oppenheimer Adjusts Molecular Templates' Price Target to $13 From $18, Maintains Outperform Rating	21-04-15	MT
MOLECULAR TEMPLATES : UBS Starts Molecular Templates at Neutral With $13 Price Target	21-02-01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW